TY - JOUR
T1 - Detection of early cartilage damage using targeted nanosomes in a post-traumatic osteoarthritis mouse model
AU - Cho, Hongsik
AU - Pinkhassik, Eugene
AU - David, Valentin
AU - Stuart, John M.
AU - Hasty, Karen A.
N1 - Funding Information:
This research was supported by National Institutes of Health (AR060408) , VA Merit Award (KAH) and funds from the Clinical and Translational Science Institute at University of Tennessee Health Science Center . This work supported was with resources and the use of facilities at the Veterans Affairs Medical Center (VAMC) at Memphis TN USA.
Publisher Copyright:
© 2015.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Osteoarthritis (OA) is a major cause of pain and disability in the US. A problem with early intervention is that it is very difficult to detect OA before irreversible damage has already occurred. This study characterizes a novel method of early OA detection in a mouse model of post-traumatic osteoarthritis (PTOA) using fluorescent nanosomes. In this investigation, knee injury was induced in mice by compressive loading. Nanosomes encapsulating fluorescent dye and conjugated to collagen type II antibody were utilized to detect cartilage damage in vivo. Cartilage damage and OA progression were detected by the use of fluorescence-imaging (IVIS) and histopathology. Histopathology analyses showed that mild osteoarthritic changes had occurred. This corresponded with a higher fluorescence on IVIS imaging due to more nanosome binding. These results suggest that theragnostic nanosomes may be useful for detection of early PTOA as well as for targeted delivery of interventional agents. From the Clinical Editor: With the aging population, osteoarthritis now poses a significant problem worldwide. Early detection may help slow the progression of the disease. In this study, the authors described the use of fluorescent nanosomes to detect early cartilage damage in a mouse model of osteoarthritis. This detection method may also prove to be useful for targeted delivery of drugs in the future.
AB - Osteoarthritis (OA) is a major cause of pain and disability in the US. A problem with early intervention is that it is very difficult to detect OA before irreversible damage has already occurred. This study characterizes a novel method of early OA detection in a mouse model of post-traumatic osteoarthritis (PTOA) using fluorescent nanosomes. In this investigation, knee injury was induced in mice by compressive loading. Nanosomes encapsulating fluorescent dye and conjugated to collagen type II antibody were utilized to detect cartilage damage in vivo. Cartilage damage and OA progression were detected by the use of fluorescence-imaging (IVIS) and histopathology. Histopathology analyses showed that mild osteoarthritic changes had occurred. This corresponded with a higher fluorescence on IVIS imaging due to more nanosome binding. These results suggest that theragnostic nanosomes may be useful for detection of early PTOA as well as for targeted delivery of interventional agents. From the Clinical Editor: With the aging population, osteoarthritis now poses a significant problem worldwide. Early detection may help slow the progression of the disease. In this study, the authors described the use of fluorescent nanosomes to detect early cartilage damage in a mouse model of osteoarthritis. This detection method may also prove to be useful for targeted delivery of drugs in the future.
KW - Extracelluar matrix (ECM)
KW - Monoclonal antibody (Mab)
KW - Nanosomes (nano-size of liposome)
KW - Near-infrared fluorescent (NIF)
KW - Osteoarthritis (OA)
KW - Post-traumatic osteoarthritis (PTOA)
KW - Theranostic (therapeutic and diagnostic)
KW - Type II collagen (CII)
UR - http://www.scopus.com/inward/record.url?scp=84929324808&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929324808&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2015.01.011
DO - 10.1016/j.nano.2015.01.011
M3 - Article
C2 - 25680539
AN - SCOPUS:84929324808
SN - 1549-9634
VL - 11
SP - 939
EP - 946
JO - Nanomedicine: Nanotechnology, Biology, and Medicine
JF - Nanomedicine: Nanotechnology, Biology, and Medicine
IS - 4
ER -